Table 1.
Correlations between CD163 and CD68 in Tumor Stroma and Tumor Nest and clinicopathologic features in primary breast cancer
| Clinicopathologic features |
CD163 |
CD68 |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Tumor Stroma |
Tumor Nest |
Tumor Stroma |
Tumor Nest |
|||||||||
| Correlation coefficient | Pvalue (2-tailed) | N | Correlation coefficient | Pvalue (2-tailed) | N | Correlation coefficient | Pvalue (2-tailed) | N | Correlation coefficient | Pvalue (2-tailed) | N | |
| Age |
−0.011 |
.91 |
121 |
0.027 |
.79 |
105 |
0.227* |
.02 |
108 |
−0.114 |
.24 |
108 |
| Nodal stage |
0.094 |
.33 |
108 |
−0.163 |
.12 |
95 |
0.18 |
.08 |
98 |
−0.008 |
.94 |
97 |
| Tumor size |
0.339** |
.000 |
121 |
0.031 |
.75 |
105 |
0.250** |
.009 |
108 |
0.033 |
.74 |
108 |
| Ki67 |
0.263** |
.007 |
104 |
0.127 |
.23 |
91 |
0.131 |
.21 |
92 |
0.05 |
.65 |
92 |
| NHG |
0.326** |
.000 |
121 |
0.091 |
.35 |
105 |
0.272** |
.004 |
108 |
0.024 |
.81 |
108 |
| Her 2 |
−0.024 |
.80 |
117 |
−0.077 |
.44 |
103 |
0.079 |
.42 |
104 |
−0.06 |
.54 |
104 |
| ER status |
−0.422** |
.000 |
121 |
−0.069 |
.48 |
105 |
−0.047 |
.63 |
108 |
0.11 |
.26 |
108 |
| PR status |
−0.395** |
.000 |
121 |
0.066 |
.50 |
105 |
−0.045 |
.64 |
108 |
0.106 |
.27 |
108 |
| Basal |
0.621** |
.000 |
118 |
−0.014 |
.89 |
103 |
0.173 |
.08 |
104 |
−0.102 |
.31 |
104 |
| Triple negative |
0.624** |
.000 |
118 |
−0.014 |
.89 |
103 |
0.173 |
.08 |
104 |
−0.102 |
.31 |
104 |
| Luminal A |
−0.514** |
.000 |
114 |
0.076 |
.45 |
100 |
−0.237* |
.02 |
100 |
0.141 |
.16 |
100 |
| Luminal B | 0.034 | .72 | 116 | −0.054 | .59 | 102 | 0.138 | .17 | 102 | −0.047 | .64 | 102 |